Basal cell carcinoma treatment—update diagnostic and therapy

被引：0

作者：

Birgit Lackner

Sara Kazerounian

Roman Dunavölgyi

Andreas Kuchar

机构：

[1] Universitätsklinik für Augenheilkunde und Optometrie, Medizinische Universität Wien, Währinger Gürtel 18–20, Wien

来源：

Spektrum der Augenheilkunde | 2015年 / 29卷 / 5-6期

关键词：

Basal cell carcinoma; Therapy; Vismodegib treatment;

D O I：

10.1007/s00717-015-0282-5

中图分类号：

学科分类号：

摘要：

Basal cell carcinoma (BCC) belongs to the most common cancer in the periorbiatl region. Because of locally advanced and metastatic BCC the therapy came in the focus of clinical research studies. The discovery of the signal transduction pathway lead to the development of a new therapeutic intervention. Vismodegib, a hedgehog pathway inhibitor, orally administered, has been introduced as therapy for locally advanced and metastastic basal cell carcinoma producing objective responses. © 2015, Springer-Verlag Wien.

引用

页码：179 / 184

页数：5

共 30 条

[1]

Lear J.T., Smith A.G., Basal cell carcinoma, Postgrad Med J, 73, 863, pp. 538-542, (1997)

[2]

Gilbody J.S., Aitken J., Green A., What causes basal cell carcinoma to be the commonest cancer?, Aust J Public Health, 18, 2, pp. 218-221, (1994)

[3]

Hackethal M., Ulrich C., Stockfleth, E. [Skin cancer after organ transplantation]. Dtsch Med Wochenschr, 131, 28-29, pp. 1609-1613, (2006)

[4]

Brash D.E., Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion, J Investig Dermatol Symp Proc, 1, 2, pp. 136-142, (1996)

[5]

Marks R., The epidemiology of non-melanoma skin cancer: who, why and what can we do about it, J Dermatol, 22, 11, pp. 853-857, (1995)

[6]

Lang G.K., Augenheilkunde, (2008)

[7]

Ninomiya Y., Photodynamic diagnosis of basal cell carcinoma on the lower eyelid using topical 5-aminolaevulinic acid and desferrioxamine, Br J Dermatol, 141, 3, pp. 580-581, (1999)

[8]

Snow S.N., Metastatic basal cell carcinoma. Report of five cases, Cancer, 73, 2, pp. 328-335, (1994)

[9]

Cook B.E., Bartley G.B., Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update, Ophthalmology. 2001

[10]

108(11):2088–98

← 1 2 3 →